维普中文期刊产品整合服务
33篇 您的检索式:作者名="Luwor"
    题名 作者 年代 出处 被引量
1Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically显示文摘Tracy L. Putoczki Stefan Thiem Andrea Loving Rita A. Busuttil Nicholas J. Wilson Paul K. Ziegler Paul Nguyen Adele Preaudet Ryan Farid Kirsten Edwards Yeliz Boglev Rodney B. Luwor Andrew Jarnicki David Horst Alex Boussioutas Joan K. Heath Oliver M. Sieber 2013Cancer Cell2013,,:2
2The role of Stat3 in glio- blastoma multiforme 显示文摘Luwor RB Stylli SS Kaye AH 2013J Clin Neurosci2013,20,7:1
3Transforming growth factor-beta (TGF-beta) and brain tumours 显示文摘Luwor R B Kaye A H Zhu H J 2008J Clin Neurosci2008,15,8:1
4The EGFRvIII variant in glioblastoma multiforme 显示文摘Gan HK Kaye AH Luwor RB 2009J Clin Neurosci2009,16,6:1
5Epidermal growth factor receptor(EGFR)ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab显示文摘Lu Y Li X Liang K Luwor R Siddik Z H Mills G B Mendelsohn J Fan Z 0,,17:1
6The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression 显示文摘Luwor RB Lu Y Li X 2005Oncogene2005,24,:1
7Monoclonal antibody 806inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor (EGFR) but not wild type EGFR显示文摘Luwor RB Johns TG Murone C 2001Cancer Res2001,61,14:1
8The EGFRvIII variant in glio-blastoma multiforme显示文摘Gan HK Kaye AH Luwor RB 2009J Clin Neurosci2009,16,6:1
9Targeting Stat3 and Smad7 to restore TGF-beta cytostatic regulation of tumor cells in vitro and in vivo显示文摘Luwor RB Baradaran B Taylor LE 2013Oncogene2013,32,19:1
10The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxiainducible factor-1 alpha,leading to transcriptional inhibition of vascular endothelial growth factor expression显示文摘Luwor RB Lu Y Li X 0,,27:1
11Inhibition of the JAK/ STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and reduced tumor burden 显示文摘Abubaker K Luwor RB Zhu H 2014BMC Cancer2014,14,:1
12Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden显示文摘Abubaker K Luwor RB Escalona R 2014Front Oncol2014,4,:1
13Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden显示文摘Abubaker K Latifi A Luwor R Nazaretian S Zhu H Quinn MA 2013Mol Cancer2013,12,1:1
14The EGFRv Ⅲ varianl in glioblastoma multiforme 显示文摘Gan H K Kaye A H Luwor R B 2009J Clin Neurosci2009,16,6:1
15The role of STAT3 in glioblastoma multiforme显示文摘Luwor RB Stylli SS Kaye AH 0,,07:1
16Short-term single treatment of chemotherapy results in the en- richment of ovarian cancer stem cell-like cells leading to an in- creased tumor burden显示文摘Abubaker K Latifi A Luwor R Nazaretian S Zhu H Quinn MA 2013Mol Cancer2013,12,:1
17The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha,leading to transcriptional inhibition of vascular endothelial growth factor expression显示文摘Luwor RB Lu Y Li X 2005Oncogene2005,24,27:1
18Isolation and characterization of tumor cells from the ascites of ovarian cancer patients:molecular phenotype of chemoresistant ovarian tumors 显示文摘Latifi A Luwor RB Bilandzic M 2012PLoS One2012,7,46:1
19The EGRFvⅢvariant in gliblastoma multiforme显示文摘Gan HK Kaye AH Luwor RB 2009J Clin Neurosci2009,16,:1
20The EGFRvlII variant in glioblasto- ma muhiforme 显示文摘Can HK Kaye AH Luwor RB 2009J Clin Neurosci2009,16,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费